A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

A healthcare technology firm was hit last week with a novel class action that accuses it of illegally mining Illinois residents' genetic testing data to train its artificial intelligence algorithms.

The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in venture capital, biological age testing has moved from academic curiosity to ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...

Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ultra-rare genetic disorders.

Abstract: The creation and assessment of a disease prediction model using genetic microarray data and the K-Nearest Neighbors (KNN) algorithm are presented in this study. The goal was to use gene ...